In a recent government meeting, Dr. Veena Singh, the medical examiner, presented a compelling case for the acquisition of Randox test kits, which are essential for the Randox Multistat analyzer—a tabletop machine that enables real-time drug testing during autopsies. This technology, acquired over a year ago with federal grant funding, has significantly improved the efficiency of toxicology testing in death investigations.

Previously, the office faced lengthy delays of four to twelve months for toxicology results from state labs or incurred substantial costs for expedited private lab testing. With approximately 900 cases annually where drug involvement is questioned, the financial burden of over $200,000 for private testing was unsustainable. The introduction of the Randox system has transformed this process, reducing the average turnaround time for toxicology cases from eight months to just one month.

Dr. Singh highlighted that the Randox test kits allow for immediate screening to determine if the office should take jurisdiction over a case and whether a full autopsy is necessary. This capability not only expedites the investigation process but also provides timely answers to families and critical information to law enforcement and public health officials.

In 2023, the office spent about $10,000 on the Randox test kits, resulting in savings of $150,000 to $200,000 compared to previous testing methods. Dr. Singh's request for a sole source declaration to purchase additional kits was met with no objections, underscoring the positive impact of this technology on public health and safety.